Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2007; 13(5): 683-691
Published online Feb 7, 2007. doi: 10.3748/wjg.v13.i5.683
Published online Feb 7, 2007. doi: 10.3748/wjg.v13.i5.683
Figure 5 Oncolytic efficacy induced by CNHK500-p53 infection evaluated by MTT assay.
Statistical analysis was performed using Student’s t test for differences among groups. Statistical significance was defined as P < 0.05. A: HCC cell lines HepG2, Bel-7402 and normal cell lines BJ, MRC-5 were infected at different MOI of 0.001-100 pfu/cell of CNHK500-p53. Cell viability was measured by MTT assay 7 d after infection. CNHK500-p53 induced a more powerful oncolysis in HCC cell lines than in normal cell lines (P < 0.05); B: Seven days after infection with virus, CNHK500-p53 not only showed more powerful cytolysis than CNHK500 and WtAd5 in HepG2, but also less profound cytolysis than WtAd5 in BJ (P < 0.05); C: IC50 of CNHK500-p53, CNHk500, and WtAd5 demonstrated significant differences among groups with a,c,eP < 0.05.
-
Citation: Zhao HC, Zhang Q, Yang Y, Lu MQ, Li H, Xu C, Chen GH. p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma
in vitro . World J Gastroenterol 2007; 13(5): 683-691 - URL: https://www.wjgnet.com/1007-9327/full/v13/i5/683.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i5.683